Insulin refusal delays glycaemic control by a year: study

Patients with type 2 diabetes play an active role in 'clinical inertia', say authors

Refusal of insulin therapy results in an average of a year’s delay for patients with type 2 diabetes to achieve glycaemic control, compared with those who accept their doctor’s advice, a US study shows.